ABC of antenatal care. Checking for fetal wellbeing--I.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to G Chamberlain.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The effects of ethamsylate and mefenamic acid on menstrual blood loss were compared in a double-blind trial in 34 women with menorrhagia. Both drugs produced statistically significant reductions in blood loss during the 3 months of treatment; the overall reduction was 20% in the ethamsylate group and 24% in the mefenamic acid group. Compared with pretreatment values, blood loss was significantly less in each of the 3 treatment months in the mefenamic acid group, but only in the second and third months of treatment in the ethamsylate group. However, more women had a clinically useful reduction in blood loss (greater than 40%) in the ethamsylate group. The onset of effect of mefenamic acid was rapid but ethamsylate showed a comparatively greater effect as the trial progressed. Cessation of treatment was followed by an increase in blood loss, more pronounced in mefenamic acid group who reverted to pre-treatment levels. A greater number of side-effects were reported with mefenamic acid.
Explore the source record for details and available documents.
To determine the association between maternal activity and pregnancy outcome, the authors investigated the separate influences of time, physical effort, and posture at work, both at a job and in the home, on birth weight. Study subjects were 1,507 of 1,889 women appearing consecutively for antenatal care at a district general hospital in inner London, England, in 1982-1984. Data were collected prospectively by interview and examination at several stages of pregnancy. Multivariable linear regression was used to distinguish associations with physical activity from confounding by other factors. The mean birth weight of infants born to women in full-time employment was 49 g less than that for births to women not in paid work (95 percent confidence interval (Cl) 1-97 g). However, the difference was due to confounding, and after adjustment, full-time employment was associated with a 12-g increase in birth weight (95 percent Cl -39 to 63 g). There was little difference in birth weight related to gestational stage at leaving work. Duration, physical effort required, and energy expenditure in paid work and in work at home had no discernible association with birth weight. A small increase in birth weight was associated with increased hours of sleep. These data allow estimates of associations with birth weight as precise as 80 g. Within the range of activities performed by pregnant women in the population studied, birth weight is unlikely to be associated with maternal physical activity.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Two hundred primiparae underwent continuous-wave Doppler investigation of the uteroplacental circulation at 18-20 weeks gestation as a possible screening test for hypertension in pregnancy. Seventy-five women with abnormal waveforms suggestive of high uteroplacental resistance were tested again at 24 weeks when 21 demonstrated a persistent abnormality. Only nine (43%) of these went on to have an uncomplicated pregnancy, as compared with 150 (84%) of the remainder. Seventeen (8.5%) of the women in the study developed a hypertensive disorder of pregnancy, five of whom had abnormal waveforms at 18-20 weeks and at 24 weeks. These five women had a more severe degree of hypertension with proteinuria or intra-uterine growth retardation, and two required clinical intervention before term. The remaining 12 women were delivered at term of average, or heavier than average babies. Doppler investigation of the uteroplacental circulation at 24 weeks may prove to be a sensitive screening test for later severe pre-eclampsia with intra-uterine growth retardation.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.